Nifty Pharma Prediction for Monday, 3 August 2026: Levels and Sector Outlook

The nifty pharma prediction for monday, 3 August 2026, centres on the index's Friday close of 26,534.80, up 188.75 points or 0.72% from Thursday's 26,346.05. Sun Pharmaceutical Industries touched a fresh 52 week high during the session, helping pharma extend its recent outperformance.

Univest analysts Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director, have built this nifty pharma prediction for monday using Friday's closing data and sector commentary gathered ahead of the weekend. Ankit Jaiswal covers the technical and sector positioning, while Kunal Singla layers in the F&O and broader market context.

Click Here – Get Free Investment Predictions

Nifty Pharma Closing Overview for the Prediction for Monday

• Nifty Pharma closed at 26,534.80 on Friday, +0.72% versus Thursday's 26,346.05 close.
• Sun Pharmaceutical Industries touched a fresh 52 week high during the session, helping pharma extend its recent outperformance.
• India VIX eased to 11.76 on Friday, a calm reading that supports a measured rather than volatile setup into next week.

Nifty Pharma Technical Analysis for the Prediction for Monday

Metric	Level
Friday Close	26,534.80 (+0.72%)
Support	26,400 / 26,150
Resistance	26,735 / 26,950

Ankit Jaiswal builds this nifty pharma prediction for monday around 26,400 as the near term pivot; holding above it keeps the setup constructive, while a close above 26,735 would open a path toward 26,950. A break below 26,150 would call for a more cautious stance in this nifty pharma prediction for monday.

F&O Context for the Nifty Pharma Prediction for Monday

Nifty Pharma does not carry its own standalone weekly F&O contract; positioning in its constituent stocks and, where relevant, the Nifty 50 or Bank Nifty derivatives feeds through indirectly. Kunal Singla flags the Nifty 50's weekly expiry on Tuesday, 4 August, as the nearest derivatives event that could add volatility to sector wide trade.

RBI Policy Week and Global Cues for the Nifty Pharma Prediction for Monday

The RBI Monetary Policy Committee meets from Monday, 3 August, to Wednesday, 5 August, with the repo rate decision due on the final day. The repo rate has held at 5.25 percent through three consecutive reviews, and most economists expect another hold.

Wall Street staged a sharp Thursday rebound, with the Nasdaq up 2.78 percent and the S&P 500 up 1.66 percent on Microsoft-led strength, a day after a Fed driven selloff. Brent crude eased to 89.03 dollars a barrel after an earlier spike above 93 dollars on Iran related strikes, and Gift Nifty August futures were trading near 24,422 on Friday morning.

Nifty Pharma Prediction for Monday: Trading Strategy

• Track Nifty Pharma's constituent stocks individually for this nifty pharma prediction for monday, since the sector does not carry deep standalone derivatives liquidity.
• Keep position sizes measured ahead of Wednesday's RBI verdict rather than building large directional bets into this nifty pharma prediction for monday.
• Use the sector's Friday direction as a starting bias for this nifty pharma prediction for monday, but confirm with Monday's opening price action before committing capital.
• Respect stop losses on individual constituent positions rather than treating this nifty pharma prediction for monday as a single tradeable instrument.

Risks to the Nifty Pharma Prediction for Monday

• A hawkish RBI surprise on Wednesday could reverse sector sentiment underlying this nifty pharma prediction for monday, particularly for rate sensitive names.
• Broader market volatility tied to the Iran-US standoff could overwhelm the sector specific drivers behind this nifty pharma prediction for monday.
• Thin standalone derivatives liquidity means sector wide moves in this nifty pharma prediction for monday can be driven by a small number of large constituents.
• A reversal in Thursday's Wall Street rally when US markets trade Friday night could shift risk appetite behind this nifty pharma prediction for monday before Monday's open.

Conclusion

This nifty pharma prediction for monday, 3 August 2026, points to a sector shaped as much by the RBI policy week as by its own internal dynamics. Ankit Jaiswal and Kunal Singla both flag Wednesday's rate verdict as the dominant trigger, with sector specific stock moves the more immediate driver into Monday's open. Traders following this nifty pharma prediction for monday should treat Friday's direction as a starting point rather than a guarantee heading into next week.

Download the Univest iOS App or Univest Android App to get the nifty pharma prediction for monday and daily sector research from SEBI registered analysts.

What is the nifty pharma prediction for monday, 3 August 2026?

Ans. The nifty pharma prediction for monday, 3 August 2026, is shaped by Friday's sector performance and the RBI policy verdict due Wednesday. Sun Pharmaceutical Industries touched a fresh 52 week high during the session, helping pharma extend its recent outperformance.

How did Nifty Pharma perform on Friday, 31 July 2026?

Ans. Sun Pharmaceutical Industries touched a fresh 52 week high during the session, helping pharma extend its recent outperformance.

How will the RBI MPC meeting affect this prediction for Monday?

Ans. The RBI Monetary Policy Committee meets from 3 to 5 August, with the rate decision due Wednesday. Rate sensitive sectors are likely to see the sharpest reaction to the verdict.

Does Nifty Pharma have its own F&O contract?

Ans. Nifty Pharma does not carry a standalone weekly derivatives contract on the exchanges Univest tracks; exposure typically comes through individual constituent stocks or broader index derivatives.

What do Ankit Jaiswal and Kunal Singla say about Nifty Pharma for Monday?

Ans. Ankit Jaiswal reads Friday's move as the starting bias for this nifty pharma prediction for monday, while Kunal Singla flags the RBI verdict on Wednesday as the dominant trigger for the sector this week.

What is the broader market backdrop heading into Monday?

Ans. The Nifty 50 closed Friday at 24,383.60, up 0.27 percent, with India VIX easing to 11.76 and FIIs net buyers of Rs 3,623.50 crore in the cash segment on 30 July.

Is there an index expiry affecting this sector on Monday?

Ans. No sector specific expiry falls on Monday. The Nifty 50 weekly expiry is Tuesday, 4 August, and the Sensex weekly expiry is Thursday, 6 August.

Should investors buy Nifty Pharma stocks ahead of the RBI policy decision?

Ans. Univest analysts suggest keeping position sizes measured ahead of Wednesday's verdict and recommend consulting a SEBI-registered financial advisor before making investment decisions.